NCT03590535View on ClinicalTrials.gov

5th Generation cTnT in ED ACS

CompletedOBSERVATIONAL
Enrollment

1,949

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

June 7, 2020

Study Completion Date

June 7, 2020

Conditions
Acute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

4th Gen cTnT

"Current Fourth Generation Cardiac Troponin T Enzyme Assay"

DIAGNOSTIC_TEST

5th Gen cTnT

"New Fifth Generation (High-sensitivity) Troponin T Enzyme Assay"

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Columbia University

OTHER

NCT03590535 - 5th Generation cTnT in ED ACS | Biotech Hunter | Biotech Hunter